The CDC alerted that doctors and state health departments should be on the lookout for monkeypox symptoms, particularly a “characteristic rash” that’s been associated with the illness.
said in its alert that clinicians "should be vigilant to the characteristic rash associated with monkeypox."
Doctors should suspect monkeypox if patients have a rash after they've traveled to countries with confirmed cases, or if a patient has reported having contact with someone who has been to one of those countries, the CDC said. The CDC added that doctors should also be suspicious of monkeypox if the patient "is a man who regularly has close or intimate in-person contact with other men, including those met through an online website, digital application , or at a bar or party."
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
CDC panel to weigh Pfizer COVID-19 booster for kids 5 to 11COVID-19 booster shots for healthy kids ages 5 to 11 will be the topic of discussion on Thursday for an influential advisory panel to the CDC, which is also expected to vote. FOX13
Les mer »
CDC Urges Covid Testing Before Domestic TravelAll travelers should now “consider getting tested as close to the time of departure as possible (no more than 3 days) before your trip,” according to the agency’s website.
Les mer »
CDC Advisers Consider Covid-19 Boosters for 5- to 11-Year-OldsA review of Pfizer’s extra dose is one of the last steps before many pharmacies, doctors and other vaccination sites begin to offer the shots.
Les mer »
CDC reports jump in mysterious hepatitis cases in childrenThe number of unexplained cases of hepatitis in children is continuing to increase.
Les mer »
180 pediatric hepatitis cases now under investigation, CDC saysThe Centers for Disease Control and Prevention is continuing to investigate mysterious hepatitis cases reported in children.
Les mer »
CDC panel OKs recommending Pfizer COVID-19 booster for kids 5 to 11The CDC must still decide whether to formally recommend the booster for this age group. Thursday’s vote by the agency’s Advisory Committee on Immunization Practices (ACIP) is part of that process, followed by a final sign-off from CDC Director Dr. Rochelle Walensky.
Les mer »